These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 26436385)
61. IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effect. Wan J; Huang F; Hu W; Hao S Biochem Biophys Res Commun; 2018 Dec; 507(1-4):122-127. PubMed ID: 30420284 [TBL] [Abstract][Full Text] [Related]
62. Importance of interleukin-7 in the development of experimental graft-versus-host disease. Chung B; Dudl E; Toyama A; Barsky L; Weinberg KI Biol Blood Marrow Transplant; 2008 Jan; 14(1):16-27. PubMed ID: 18158957 [TBL] [Abstract][Full Text] [Related]
63. Stromal-Derived Factor-1α and Interleukin-7 Treatment Improves Homeostatic Proliferation of Naïve CD4(+) T Cells after Allogeneic Stem Cell Transplantation. Gauthier SD; Leboeuf D; Manuguerra-Gagné R; Gaboury L; Guimond M Biol Blood Marrow Transplant; 2015 Oct; 21(10):1721-31. PubMed ID: 26151303 [TBL] [Abstract][Full Text] [Related]
64. Mouse nidovirus LDV infection alleviates graft versus host disease and induces type I IFN-dependent inhibition of dendritic cells and allo-responsive T cells. Gaignage M; Marillier RG; Uyttenhove C; Dauguet N; Saxena A; Ryffel B; Michiels T; Coutelier JP; Van Snick J Immun Inflamm Dis; 2017 Jun; 5(2):200-213. PubMed ID: 28474504 [TBL] [Abstract][Full Text] [Related]
65. [Effects of Tripterygium hypoglaucum (level) Hutch extraction on regulatory T cells in mice after allogeneic bone marrow transplantation]. Li S; Xu KL; Li ZY Zhongguo Zhong Xi Yi Jie He Za Zhi; 2009 Oct; 29(10):910-4. PubMed ID: 20073223 [TBL] [Abstract][Full Text] [Related]
66. Purification of placenta-eluted gamma globulins and their strong effect against graft-versus-host reactions in vitro and in vivo. Liu F; Lu DP Int J Hematol; 2005 Aug; 82(2):162-8. PubMed ID: 16146851 [TBL] [Abstract][Full Text] [Related]
67. [Source and effect of IL-22 in graft versus host disease mouse after allo-genetic bone marrow transplantation]. Zhao K; Huang D; Zhao DM; Chen C; Wu QY; Pan B; Zeng LY; Li ZY; Xu KL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1526-9. PubMed ID: 24370042 [TBL] [Abstract][Full Text] [Related]
68. Th2 cell therapy of established acute graft-versus-host disease requires IL-4 and IL-10 and is abrogated by IL-2 or host-type antigen-presenting cells. Foley JE; Mariotti J; Ryan K; Eckhaus M; Fowler DH Biol Blood Marrow Transplant; 2008 Sep; 14(9):959-972. PubMed ID: 18721759 [TBL] [Abstract][Full Text] [Related]
69. Critical role of host gammadelta T cells in experimental acute graft-versus-host disease. Maeda Y; Reddy P; Lowler KP; Liu C; Bishop DK; Ferrara JL Blood; 2005 Jul; 106(2):749-55. PubMed ID: 15797996 [TBL] [Abstract][Full Text] [Related]
70. [Study on control of graft-versus-host disease by blocking CD137-CD137L ligand costimulatory pathway in mice]. Li CH; Xu KL; Pan XY; Du B Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):93-7. PubMed ID: 17650668 [TBL] [Abstract][Full Text] [Related]
72. Host MyD88 signaling protects against acute graft-versus-host disease after allogeneic bone marrow transplantation. Xing S; Zhang X; Liu JH; Huang X; Zhou P Clin Exp Immunol; 2019 Jan; 195(1):121-131. PubMed ID: 30317551 [TBL] [Abstract][Full Text] [Related]
73. Differential Effects of Gut-Homing Molecules CC Chemokine Receptor 9 and Integrin-β7 during Acute Graft-versus-Host Disease of the Liver. Schreder A; Moschovakis GL; Halle S; Schlue J; Lee CW; Schippers A; David S; Bernhardt G; Ganser A; Pabst O; Förster R; Koenecke C Biol Blood Marrow Transplant; 2015 Dec; 21(12):2069-2078. PubMed ID: 26348893 [TBL] [Abstract][Full Text] [Related]
74. IFN-gamma activation of mesenchymal stem cells for treatment and prevention of graft versus host disease. Polchert D; Sobinsky J; Douglas G; Kidd M; Moadsiri A; Reina E; Genrich K; Mehrotra S; Setty S; Smith B; Bartholomew A Eur J Immunol; 2008 Jun; 38(6):1745-55. PubMed ID: 18493986 [TBL] [Abstract][Full Text] [Related]
75. [The role of IL-22 on thymus recovery and its function in mice following allogeneic bone marrow transplantation]. Zhao K; Zhao D; Yin L; Pan B; Xu K Zhonghua Xue Ye Xue Za Zhi; 2014 Sep; 35(9):822-5. PubMed ID: 25246251 [TBL] [Abstract][Full Text] [Related]
76. Graft-versus-host disease in the absence of the spleen after allogeneic bone marrow transplantation. Clouthier SG; Ferrara JL; Teshima T Transplantation; 2002 May; 73(10):1679-81. PubMed ID: 12042660 [TBL] [Abstract][Full Text] [Related]
77. Interleukin-11 promotes T cell polarization and prevents acute graft-versus-host disease after allogeneic bone marrow transplantation. Hill GR; Cooke KR; Teshima T; Crawford JM; Keith JC; Brinson YS; Bungard D; Ferrara JL J Clin Invest; 1998 Jul; 102(1):115-23. PubMed ID: 9649564 [TBL] [Abstract][Full Text] [Related]
78. [Immunomodulatory effects of human placental-derived mesenchymal stem cells on immune rejection in mouse allogeneic skin transplantation]. Wang Q; Liu T; Zhang Y; Chen D; Wang L; Li Y; Wei J Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Jul; 27(7):775-80. PubMed ID: 24063162 [TBL] [Abstract][Full Text] [Related]
79. Effect of hyperbaric oxygen on acute graft-versus-host disease after allogeneic bone marrow transplantation. Song XY; Sun LN; Zheng NN; Zhang HP Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):623-6. PubMed ID: 18549642 [TBL] [Abstract][Full Text] [Related]